Science

CSIR-IIP to set up viral testing facility to fight Covid-19

Umashankar Mishra New Delhi | Updated on May 02, 2020 Published on May 02, 2020

The Indian Institute of Petroleum (IIP) is establishing an RT-PCR-based Covid-19 testing facility in its Dehradun campus. Indian Institute of Petroleum (IIP) is a constituent laboratory of Council of Scientific and Industrial Research (CSIR).

CSIR has planned a community testing strategy to keep track of new outbreaks and thus restrict them from spreading further. “CSIR-Indian Institute of Petroleum (IIP) has always believed in working for national causes. Testing samples for Covid-19 is another opportunity where we assure our full commitment in line with protocols and standard operating procedures defined by the Indian Council of Medical Research (ICMR). This new Covid-19 testing facility will process at least 30 patient samples per day with appropriately trained manpower and adequate biosafety precautions”, said Dr Anjan Ray, Director, CSIR-IIP.

The Biochemistry and Biotechnology team at CSIR-IIP is receiving continuous expert guidance from CSIR's specialized biological sciences laboratories such as CSIR-Institute of Genomics and Integrative Biology (IGIB) (Delhi), CSIR-Institute of Microbial Technology (IMTECH) (Chandigarh) and CSIR-Centre for Cellular and Molecular Biology (CCMB) (Hyderabad) to enable their active participation in the fight against coronavirus.

CSIR-IIP is in constant touch with Uttarakhand state health ministry and all government hospitals to make the facility fully operational and initiate testing by mid-May. This state-of-the-art testing facility will be available for the long term as a state resource centre for viral testing, as well as a key part of the planned environmental biotechnology centre of excellence at CSIR-IIP.

“This effort will augment the capacity of the limited public testing facilities across Uttarakhand and help share a load of patient samples from the populous Dehradun district, which is currently supported for testing only by AIIMS (Rishikesh) and Doon Hospital. Additionally, CSIR-IIP is also planning to adopt a faster micro RT-PCR-based analysis method for sample screening under the technical supervision of CSIR-IGIB”, said Dr Ray.

Health experts believe that more testing can help in surveillance of Covid-19 outbreak. One of the commonly accepted methods of diagnosis approved by the World Health Organization (WHO) is through the real-time reverse transcription PCR (RT-PCR) technique, wherein the researchers extract nucleic acid from the collected samples from individuals (typically either a nasal or throat swab, or saliva) and amplify parts of the viral genome via RT-PCR. The test is positive if the samples harbour any viral RNA and return a negative result if the viral RNA is absent.

Other than this testing effort, CSIR-IIP is providing the free supply of in-house produced hand sanitizer in bulk to local hospitals and police stations, and masks to sanitation workers and needy migrants. The Institute is also developing a low-cost oxygen concentrator for medical use, using the lab's industry-proven capability of adsorptive gas separation.

Twitter handle: @usm_1984

(India Science Wire)

Published on May 02, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Sincerely,

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.